MENTOR, Ohio -- STERIS Corporation announces that Timothy L. Chapman has been promoted to senior vice president and group president of healthcare. Chapman joined the company in January 2006 as senior vice president of business strategy. In his new role, Chapman replaces Charles L. Immel, who has decided to pursue other opportunities outside the company.
Chapman, 45, will report to Walt Rosebrough, president and chief executive officer, and will have responsibility for the companys healthcare segment, a leading provider of infection prevention and surgical equipment, consumables and services to customers such as acute care hospitals and outpatient surgical centers. Chapman will also retain responsibility for the companys business strategy function.
We are very fortunate to have a top performer like Tim for such a significant role in the company, said Walt Rosebrough, president and chief executive officer of STERIS. Tim has considerable experience in healthcare, not only at STERIS, but across the industry and has a deep understanding of the market and our customers. I am confident that Tim will bring considerable perspective and leadership to his role. Chuck Immel has made a number of contributions to STERIS Corporation over the past seven years and we all wish him the best in his career beyond STERIS.
During his time at STERIS, Chapman has had responsibility for leading STERISs strategic planning, business development and supply chain management activities where he has established greater discipline and structure in the companys processes. Additionally, Chapman has worked closely with healthcare customers to better understand their needs and form relationships with them to improve performance across a range of activities.
Prior to joining STERIS Corporation, Chapman was a director of McKinsey & Companys Cleveland office and served as a leader in the firms healthcare practice for 15 years, working closely with numerous healthcare institutions on a broad range of organizational, strategic and operational issues. He also founded and led the purchasing and supply chain management practice while at McKinsey.
Chapman earned a bachelors degree in economics from Dartmouth College and a masters degree in business administration with distinction from the Amos Tuck School at Dartmouth. He is a board member of the Make-A-Wish Foundation of Greater Ohio and Kentucky, and previously served that organization as a national board member.
Source: STERIS Corp.
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.